Neuroinflammation is neither uniformly protective nor uniformly destructive. Its effect depends on cell state, duration and the integrity of the barriers around the compartment.
Inflammation in the nervous system is a repair programme that becomes pathological when it fails to resolve. The same microglial activation that clears debris after acute injury drives synaptic loss when it is sustained for months. Duration and cell state, not the presence of inflammation, determine the outcome.
Microglial priming
Primed microglia respond to a second stimulus far more strongly than naive cells. This history-dependence explains why identical challenges produce divergent outcomes across patients and why cross-sectional inflammatory markers correlate so poorly with progression.
Peripheral immune trafficking
In autoimmune neurology, peripherally activated lymphocytes cross a compromised barrier and encounter antigens they would not normally see. The resulting response is amplified by resident glia. Interventions that act only on the peripheral compartment often leave the resident amplification loop intact.
- Barrier integrity is a modifiable variable, not a fixed property.
- Resident and infiltrating populations require separate readouts.
- Resolution pathways deserve as much attention as initiation pathways.
Implications for therapeutic design
Broad immunosuppression trades progression risk for infection and impaired repair. Our preclinical work therefore prioritises interventions that shift glial state and restore resolution rather than interventions that suppress the response wholesale.
This article describes preclinical research. Cytosomatic Labs does not treat patients, sell products or provide medical advice.